Brevan Howard Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$505K Sell
2025
Q2
$1.49M Buy
2025
Q1
$779K Buy
2024
Q3
Sell
2024
Q2
$311K Buy
2024
Q1
Sell
2023
Q4
$271K Buy